|
|
|
|
LEADER |
01349nab a2200373 i 4500 |
001 |
publ23111 |
005 |
20220104093522.0 |
008 |
220104s2021 hu o 0|| Angol d |
022 |
|
|
|a 0923-7534
|
024 |
7 |
|
|a 10.1016/j.annonc.2020.12.013
|2 doi
|
024 |
7 |
|
|a 32546756
|2 mtmt
|
040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
041 |
|
|
|a Angol
|
100 |
1 |
|
|a Martin M.
|
245 |
1 |
0 |
|a Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer
|h [elektronikus dokumentum] :
|b a phase III randomised controlled trial—PEARL /
|c Martin M.
|
260 |
|
|
|c 2021
|
300 |
|
|
|a 488-499
|
490 |
0 |
|
|a ANNALS OF ONCOLOGY
|v 32 No. 4
|
650 |
|
4 |
|a Klinikai orvostan
|
700 |
0 |
1 |
|a Zielinski C.
|e aut
|
700 |
0 |
2 |
|a Ruiz-Borrego M.
|e aut
|
700 |
0 |
2 |
|a Carrasco E.
|e aut
|
700 |
0 |
2 |
|a Turner N.
|e aut
|
700 |
0 |
2 |
|a Ciruelos E. M.
|e aut
|
700 |
0 |
2 |
|a Muñoz M.
|e aut
|
700 |
0 |
2 |
|a Bermejo B.
|e aut
|
700 |
0 |
2 |
|a Margeli M.
|e aut
|
700 |
0 |
2 |
|a Anton A.
|e aut
|
700 |
0 |
2 |
|a Kahán Zsuzsanna
|e aut
|
700 |
0 |
2 |
|a Csöszi Tibor
|e aut
|
700 |
0 |
2 |
|a Casas M. I.
|e aut
|
700 |
0 |
2 |
|a Murillo L.
|e aut
|
700 |
0 |
2 |
|a Morales S.
|e aut
|
856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/23111/1/1-s2.0-S0923753420432211-main.pdf
|z Dokumentum-elérés
|